Aimmune Therapeutics: 3Q Earnings Snapshot
BRISBANE, Calif. (AP) _ Aimmune Therapeutics Inc. (AIMT) on Thursday reported a loss of $51.7 million in its third quarter.
The Brisbane, California-based company said it had a loss of 89 cents per share.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.
Aimmune Therapeutics shares have decreased 25 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $28.25, a decline of nearly 9 percent in the last 12 months.